CYTODYN INC.

Profile

Company Names

CYTODYN INC.
CYTODYN INC

Addresses

1111 MAIN STREET, SUITE 660, VANCOUVER, WA 98660

1111 MAIN STREET, SUITE 600, VANCOUVER, WA 98660

1111 MAIN STREET, SUITE 660, VANCOUVER, WA 98660

5 CENTERPOINTE DRIVE, SUITE 400, LAKE OSWEGO, OR 97035

110 CRENSHAW LAKE ROAD, LUTZ, FL 33548

1511 THIRD STREET, SANTA FE, NM 87505

Phone Numbers

360-980-8524
971-204-0382
813-527-6969
505-988-5520

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

COLORADO

Total Amount Raised:

$173,492,411.00

Number of Funding Rounds:

20
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
20
2026-01-30 
$18,600,392.00 
$18,600,392.00 
$0.00 
Equity 
19
2022-04-07 
$21,771,535.00 
$21,771,535.00 
$0.00 
Equity 
18
2021-11-17 
$11,361,000.00 
$53,593,700.00 
$42,232,700.00 
Equity 
17
2021-08-31 
$2,872,000.00 
$25,220,000.00 
$22,348,000.00 
Equity 
16
2020-11-07 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
15
2020-03-13 
$882,000.00 
$1,157,625.00 
$275,625.00 
Equity 
14
2020-01-31 
$7,570,000.00 
$11,355,000.00 
$3,785,000.00 
Equity 
13
2019-03-20 
$7,788,000.00 
$20,000,000.00 
$12,212,000.00 
Equity 
12
2018-08-28 
$13,199,385.00 
$25,000,000.00 
$11,800,615.00 
Equity 
11
2017-11-02 
$17,643,452.00 
$17,643,452.00 
$0.00 
Equity 
10
2017-05-31 
$1,150,000.00 
$15,000,000.00 
$13,850,000.00 
Debt 
9
2016-04-26 
$4,301,500.00 
$10,000,000.00 
$5,698,500.00 
Equity 
8
2015-09-21 
$2,693,800.00 
$3,981,050.00 
$1,287,250.00 
Equity 
7
2015-06-30 
$33,268,465.00 
$33,268,465.00 
$0.00 
Equity 
6
2015-04-30 
$3,281,050.00 
$4,000,000.00 
$718,950.00 
Debt 
5
2013-09-25 
$14,500,000.00 
$14,500,000.00 
$0.00 
Equity 
4
2012-10-01 
$7,788,250.00 
$10,000,000.00 
$2,211,750.00 
Equity, Debt 
3
2012-07-27 
$575,500.00 
$575,500.00 
$0.00 
Equity 
2
2011-12-07 
$2,996,082.00 
$3,000,000.00 
$3,918.00 
Equity 
1
2009-11-03 
$250,000.00 
$1,000,000.00 
$750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALLEN 
D 
ALLEN 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC
CORINNE 
 
ALLEN 
EXECUTIVE OFFICER
CYTODYN INC
ARVIN 
CYRUS 
ARMAN 
EXECUTIVE OFFICER
CYTODYN INC.
TYLER 
 
BLOK 
EXECUTIVE OFFICER
CYTODYN INC.
KAREN 
J. 
BRUNKE 
DIRECTOR
CYTODYN INC.
KAREN 
J. 
BRUNKE, PH.D. 
DIRECTOR
CYTODYN INC.
DENIS 
R. 
BURGER 
DIRECTOR
CYTODYN INC   |  CYTODYN INC.
ANTHONY 
 
CARACCIOLO 
DIRECTOR
CYTODYN INC
ANTHONY 
D. 
CARACCIOLO 
DIRECTOR, EXECUTIVE OFFICER
CYTODYN INC   |  CYTODYN INC.
ANTHONY 
D. 
CARRACIOLO 
DIRECTOR
CYTODYN INC
ARIAN 
 
COLACHIS 
EXECUTIVE OFFICER
CYTODYN INC.
GEORGE 
 
DEMBOW 
DIRECTOR
CYTODYN INC
GEORGE 
F. 
DEMBOW 
DIRECTOR
CYTODYN INC
CARL 
C. 
DOCKERY 
DIRECTOR
CYTODYN INC   |  CYTODYN INC.   |  AYTU BIOSCIENCE, INC
RYAN 
 
DUNLAP 
DIRECTOR
GALENA BIOPHARMA, INC.   |  MOLECULARMD CORP.   |  CYTODYN INC.
RYAN 
M. 
DUNLAP 
DIRECTOR
CYTODYN INC.
CRAIG 
 
EASTWOOD 
EXECUTIVE OFFICER
CYTODYN INC.
MAURA 
 
FLEMING 
EXECUTIVE OFFICER
CYTODYN INC.
GORDON 
A. 
GARDINER 
DIRECTOR
CONCORDIA COFFEE CO INC   |  FUTURO ESPRESSO LLC   |  TABLESAFE, INC.   |  CYTODYN INC.
GREGORY 
 
GOULD 
DIRECTOR
OHIO RIVER TRADING CO   |  NORTH AMERICAN LIMESTONE CORP   |  CYTODYN INC
GREGORY 
A 
GOULD 
DIRECTOR
CYTODYN INC
GREGORY 
A. 
GOULD 
DIRECTOR
CYTODYN INC   |  AYTU BIOSCIENCE, INC   |  CYTODYN INC.   |  AJNA BIOSCIENCES PBC   |  CHARLOTTE-S WEB HOLDINGS, INC.
GEORGE 
 
GOULD, CPA 
DIRECTOR
CYTODYN INC
GREGORY 
A. 
GOULD, CPA 
DIRECTOR
CYTODYN INC
ALLAN 
 
GREEN 
DIRECTOR
CYTODYN INC   |  SABIK MEDICAL INC.   |  RATIO THERAPEUTICS, INC.
ROBERT 
E. 
HOFFMAN 
EXECUTIVE OFFICER
ARENA PHARMACEUTICALS INC   |  ASLAN PHARMACEUTICALS LTD   |  CYTODYN INC.
SCOTT 
A 
KELLY 
DIRECTOR
CYTODYN INC.
SCOTT 
A. 
KELLY 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC.
SCOTT 
 
KELLY, M.D. 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC.
SCOTT 
A 
KELLY, M.D. 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC.
MICHAEL 
A. 
KLUMP 
DIRECTOR
RCG VENTURES DISTRESSED REAL ESTATE OPPORTUNITY FUND, LP   |  PEAK RESTAURANT PARTNERS, LP   |  K-SQUARE RESTAURANT PARTNERS, LP   |  NEIGHBORHOOD RESTAURANT PARTNERS FLORIDA, LP   |  RCG VENTURES FUND III, LP   |  BORDER PARTNERS LP   |  ARGONNE AUTOMOTIVE PARTNERS, LP   |  ALLIANCE PANCAKE PARTNERS, LP   |  KEYSTONE PARTNERS, LP   |  LANDPRO EQUIPMENT PARTNERS LP   |  KRYSTAL PARENT HOLDINGS, LP   |  ARGONNE CAPITAL PARTNERS I, LP   |  KEYSTONE PF HOLDINGS, LLC   |  BORDER PARENT HOLDINGS, LP   |  ARGONNE CAPITAL PARTNERS PARALLEL I, LP   |  CYTODYN INC.   |  ACP KEYSTONE PF PARTNERS, LP   |  ACP KEYSTONE PF HOLDINGS SUB, LLC   |  PLANET FITMEX, LLC   |  SRP CONTINUATION PARTNERS, LP   |  SRP CONTINUATION PARTNERS PARALLEL, LP   |  NFP CONTINUATION PARTNERS PARALLEL, LP   |  NFP CONTINUATION PARTNERS, LP   |  NFP CONTINUATION PARTNERS II, LP   |  NFP CONTINUATION PARTNERS PARALLEL II, LP   |  PLANET FITMEX PARALLEL, LLC   |  NFP ROLLOVER PARTNERS, LP   |  ACG FIREWORKS PARTNERS, LP   |  NFP ROLLOVER PARTNERS II, LP   |  NFP CONTINUATION PARTNERS MANAGEMENT HOLDCO, LLC   |  NFP CONTINUATION PARTNERS A-2, LP
JACOB 
P. 
LALEZARI 
EXECUTIVE OFFICER
CYTODYN INC.
ANDREW 
 
LIBBY 
EXECUTIVE OFFICER
CYTODYN INC
ANDREW 
T. 
LIBBY, JR. 
EXECUTIVE OFFICER
CYTODYN INC
ANTONIO 
 
MIGLIARESE 
EXECUTIVE OFFICER
CYTODYN INC.
ANTONIO 
 
MIGLIARESE, C.P.A. 
EXECUTIVE OFFICER
CYTODYN INC.
ALAN 
BRUCE 
MONTGOMERY 
DIRECTOR
CYTODYN INC   |  CYTODYN INC.   |  VICIS, INC.   |  ALDER BIOPHARMACEUTICALS INC
MICHAEL 
 
MULHOLLAND 
EXECUTIVE OFFICER
NIKKO AM WORLD BANK GREEN FUND, A SUB-FUND OF NIKKO AM GLOBAL UMBRELLA FUND   |  CYTODYN INC
MICHAEL 
D. 
MULHOLLAND 
EXECUTIVE OFFICER
CYTODYN INC   |  CYTODYN INC.
JORDAN 
 
NAYDENOV 
DIRECTOR
CYTODYN INC
JORDAN 
G 
NAYDENOV 
DIRECTOR
CYTODYN INC.
JORDAN 
G. 
NAYDENOV 
DIRECTOR
CYTODYN INC   |  CYTODYN INC.
LISHOMWA 
C. 
NDHLOVU 
DIRECTOR
CYTODYN INC.
LISHOMWA 
C. 
NDHLOVU, M.D., PH.D. 
DIRECTOR
CYTODYN INC.
MICHAEL 
 
NOBEL 
DIRECTOR
CYTODYN INC
S. MICHAEL 
 
NOBEL 
DIRECTOR
CYTODYN INC
SAMIR 
R. 
PATEL, M.D. 
DIRECTOR
CYTODYN INC.
RICHARD 
G. 
PESTELL 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC.
NADAR 
 
POURHASSAN 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC
NADAR 
Z. 
POURHASSAN 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC   |  CYTODYN INC.
NADER 
 
POURHASSAN 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC
NADER 
Z 
POURHASSAN 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC.
NADER 
Z. 
POURHASSAN 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC.
NADER 
Z 
POURHASSAN, PH.D 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC.
NADER 
Z. 
POURHASSAN, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC.
MAHBOOB 
 
RAHMAN, M.D., PH.D. 
EXECUTIVE OFFICER
CYTODYN INC.
NITYA 
G. 
RAY 
EXECUTIVE OFFICER
CYTODYN INC.
NITYA 
G. 
RAY, PH.D. 
EXECUTIVE OFFICER
CYTODYN INC.
CHRISTOPHER 
 
RECKNOR 
EXECUTIVE OFFICER
CYTODYN INC.
CHRISTOPHER 
 
RECKNOR, M.D. 
EXECUTIVE OFFICER
CYTODYN INC.
HARISH 
 
SEETHAMRAJU 
DIRECTOR
CYTODYN INC.
STEPHEN 
M. 
SIMES 
DIRECTOR
CYTODYN INC.
ALAN 
P 
TIMMINS 
DIRECTOR
CYTODYN INC.
ALAN 
P. 
TIMMINS 
DIRECTOR
PAULSON CAPITAL CORP   |  CYTODYN INC.
RICHARD 
 
TRAUGER 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC
RONALD 
 
TROPP 
DIRECTOR
CYTODYN INC
RONALD 
J 
TROPP 
DIRECTOR
CYTODYN INC
RONALD 
J. 
TROPP, ESQ. 
DIRECTOR
CYTODYN INC
TANYA 
D. 
URBACH 
DIRECTOR
CYTODYN INC.
TANYA 
DURKEE 
URBACH 
DIRECTOR
CYTODYN INC.
KENNETH 
 
VAN NESS 
DIRECTOR
CYTODYN INC
KENNETH 
J. 
VAN NESS 
EXECUTIVE OFFICER, DIRECTOR
CYTODYN INC
DAVID 
F 
WELCH 
DIRECTOR
CYTODYN INC.
DAVID 
F. 
WELCH 
DIRECTOR
ANTRIABIO, INC.   |  REZOLUTE, INC.   |  INFINERA CORP   |  CYTODYN INC.   |  AXIADO CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-01-30 
2022-09-19
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-04-07 
2022-04-25
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-04-07 
2022-04-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-04-07 
2021-12-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-17 
2021-09-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-08-31 
2020-12-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-11-07 
2020-04-07
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-01-31 
2020-03-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-13 
2020-02-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-01-31 
2019-11-12
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-03-20 
2019-04-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-03-20 
2018-09-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-28 
2018-02-28
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-11-02 
2017-11-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-11-02 
2017-06-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-05-31 
2016-05-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-04-26 
2016-02-23
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-30 
2015-10-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-09-21 
2015-07-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-30 
2015-05-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2015-04-30 
2013-10-29
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-09-25 
2013-09-25
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-09-25 
2013-08-05
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity, Debt 
2012-10-01 
2013-02-15
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity, Debt 
2012-10-01 
2012-10-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity, Debt 
2012-10-01 
2012-09-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2012-07-27 
2012-01-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2011-12-07 
2009-11-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2009-11-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PAULSON INVESTMENT COMPANY
5670
NONE
NONE
PAULSON INVESTMENT COMPANY
2670
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
5670
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
5670
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
5670
NONE
NONE
PAULSON INVESTMENT COMPANY, INC.
5670
NONE
NONE
PAULSON INVESTMENT COMPANY, INC.
5670
NONE
NONE
SPENCER EDWARDS INC.
22067